Description:

Northwestern University's Querrey InQbation Lab is hosting the FoundHer Stories series to amplify the startup stories of women scientist entrepreneurs.

Learn about Dr. Elizabeth Wood’s experience co-founding JURA Bio in 2017 alongside Prof. George Church (Harvard) and former Church lab postdoc, Dr. Julie Norville. Dr. Wood will share how her company harnesses a combination of synthetic biology and machine learning to build an end-to-end discovery and development platform for developing immune-based therapeutics. 

While the FoundHer Stories series is focused on supporting women innovators and entrepreneurs, all are welcome to register.

Please register in advance.

OUR SPEAKER

Elizabeth Wood, Ph.D., is the co-founder and CEO of JURA Bio, Inc., an early-stage therapeutics company focusing on developing and delivering cell-based therapies for the treatment of autoimmune and immune-related neurodegenerative disease. Before starting JURA, Wood was a post-doc in the lab of Adam Cohen at Harvard’s Department of Chemistry and Physics. She began her PhD with Angela Belcher and Markus Buehler at MIT, and finished it under the supervision of Claus Helix-Nielsen at The Technical University of Denmark, Departments of Physics and Civil and Environmental Engineering. She has also worked at the University of Copenhagen’s SBiN Lab with Kresten Lindorff-Larsen, integrating computational methods with experimental studies to better predict RNA structure and to understand how the ability of proteins to change their shape helps modulate their function. Wood is a visiting scientist at the Broad Institute, where she serves on the steering committee of MIA. Since 2019 she has served as the primary organizer of the NeurIPS Workshop Learning Meaningful Representations of Life. She currently serves on the board of Pure Home Water Ghana and Project Clio.

https://northwestern.zoom.us/j/97830552706